Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker XBIO
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 23, 2026 | XBIO Xenetic Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 16, 2026 | XBIO Xenetic Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 16, 2026 | XBIO Xenetic Biosciences, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Sep 16, 2026 | XBIO Xenetic Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 7, 2026 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2026 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 24, 2026 | XBIO Xenetic Biosciences, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 13, 2026 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 9, 2026 | XBIO Xenetic Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 11, 2025 | XBIO Xenetic Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 13, 2025 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 14, 2025 | XBIO Xenetic Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 14, 2025 | XBIO Xenetic Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 13, 2025 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 14, 2025 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 10, 2025 | XBIO Xenetic Biosciences, Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Mar 19, 2025 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 13, 2024 | XBIO Xenetic Biosciences, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Nov 13, 2024 | XBIO Xenetic Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2024 | XBIO Xenetic Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 7, 2024 | XBIO Xenetic Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 31, 2024 | XBIO Xenetic Biosciences, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
23 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:21 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances